Quantcast

Latest Shire Stories

2011-04-26 13:27:00

DUBLIN, April 26, 2011 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company (the "Company") announces that at its Annual General Meeting today, all resolutions contained in the notice of meeting were duly passed and the results of the poll are as follows: For* Against Withheld** 1. To receive the 434,920,990 99.46% 2,344,010 0.54% 1,047,773 Company's...

2010-10-18 10:51:00

DUBLIN, October 18, 2010 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, will announce third quarter 2010 earnings on Friday 29 October, 2010. Results press release will be 12:00 BST / 07:00 EDT issued at: Investor conference call 14:00 BST / 09:00 EDT time: Live conference call for investors: Angus Russell, Chief Executive Officer and Graham Hetherington, Chief Financial Officer will host the...

2010-08-17 12:49:00

PHILADELPHIA, Pennsylvania, August 17, 2010 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY) acquired ProAmatine as a part of the acquisition of Roberts Pharma in 1999 and Shire conducted and completed the post marketing trials that the FDA required. The FDA, however, viewed these trials as inconclusive and required that additional trials be conducted for ProAmatine to maintain its marketing authorization. As a result, Shire elected to withdraw the product effective September...

2010-07-15 05:59:00

DUBLIN, Ireland, July 15, 2010 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, will announce second quarter 2010 earnings on Wednesday August 4, 2010. Results press release will be issued at: 12:00 BST / 07:00 EDT Investor conference call time: 14:00 BST / 09:00 EDT Live conference call for investors: Angus Russell, Chief Executive Officer and Graham Hetherington, Chief Financial Officer...

2010-06-30 12:10:00

LEXINGTON, Massachusetts, June 30, 2010 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced its purchase of the Lexington Technology Park campus in Lexington, Massachusetts. The purchase signifies an investment in the growth of its Human Genetic Therapies (HGT) business, which focuses on the discovery, development, and manufacturing of treatments for rare genetic diseases. Shire had previously leased three...

2010-05-10 13:15:00

PHILADELPHIA, May 10 /PRNewswire/ -- Even with a steadily improving economy, 130,000 children and families across the Greater Philadelphia region are struggling to make ends meet. This spring, Shire Pharmaceuticals is issuing a "call to action" for residents in Southeastern Pennsylvania with its third annual BIG GIVE regional donation drive to benefit Cradles to Crayons. Most Cradles to Crayons recipients have incomes of $15,000 or below and need basic necessities like socks, backpacks,...

2010-03-10 06:00:00

YARDLEY, Pa., March 10 /PRNewswire/ -- After reviewing more than 13,000 entries, the Telly Awards® and their Silver Council announced the Shire and PharmtoMarket (P2M) produced "ADHD News Network Broadcast: 11/18/2009" had received the coveted 2010 Telly Award for video broadcasting and production. Executive Producers for Shire, Jeff Roeseler and Nate Capone, were recognized along with Connie Ferrara of P2M for their outstanding work in producing the hour-long, live...

2010-02-16 11:27:00

FREMONT, Calif., Feb. 16 /PRNewswire/ -- ValGenesis, Inc., a world-class leading provider of Validation Lifecycle Management (VLM) software solutions, today announced that Shire HGT has implemented ValGenesis software as its platform for validation process management. Shire HGT had been seeking a robust validation management software solution to replace its in-house developed system. Upon completion of their evaluation, Shire HGT determined that ValGenesis offered significant improvement...

2009-12-02 06:00:00

PHILADELPHIA, Pennsylvania, December 2 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announces that it has settled the litigation with Teva Pharmaceuticals USA, Inc. ("Teva") over Shire's supply to Teva of an authorized generic version of ADDERALL XR. Shire has been supplying Teva with authorized generic ADDERALL XR since April 1, 2009. Shire's ability to supply the product had been limited by restrictions that the US Drug...

2009-04-28 10:34:00

DUBLIN, April 28 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announces that at its Annual General Meeting today, all resolutions contained in the notice of meeting were duly passed and the results of the poll are as follows: For* Against Withheld** 1. To receive the Company's accounts together with the director's and...


Word of the Day
endocarp
  • The hard inner (usually woody) layer of the pericarp of some fruits (as peaches or plums or cherries or olives) that contains the seed.
This word comes from the Greek 'endon,' in, within, plus the Greek 'kardia,' heart.
Related